Yaakov Nahmias

Last updated
Yaakov Nahmias
BornApr, 1974
Tel Aviv, Israel
Nationality Israeli
Alma mater Technion – Israel Institute of Technology, University of Minnesota
AwardsNIH Research Scientist Development Award (K01), 2008; Golda Meir Fellowship, 2009; Marie Curie Reintegration Grant, 2010; European Research Council Starting Grant, 2011; Rappaport Prize for Biomedical Sciences, 2014; European Research Council Consolidator Grant, 2016;
Scientific career
Fields Liver Biology, Systems Biology, Biomedical Engineering
Institutions Hebrew University of Jerusalem, Harvard Medical School
Doctoral advisor David Odde

Yaakov "Koby" Nahmias is an Israeli biomedical engineer and entrepreneur. Nahmias is a professor at the Hebrew University of Jerusalem and an affiliated member of the NIH-funded BioMEMS Resource Center at Massachusetts General Hospital.

Contents

Nahmias is the founding director of the Alexander Grass Center for Bioengineering. He is a co-founder of Israel’s BioDesign Medical Innovation program, recently listed as a major reason for Boston Scientific's continued investment in Israel. [1]

In 2014, he won the Rappaport Prize for Biomedical Sciences for his “groundbreaking work on liver tissue engineering” and the “development of nanotechnology therapies for the treatment of diabetes”. [2] [3]

Nahmias edited a book titled Microdevices in Biology and Medicine, and is currently serving as a technology consultant for L’Oreal, [4] and a member of the European Research Council panel for applied life sciences and biotechnology. [5]

In 2018, Nahmias became the co-founder and chief scientific officer of Future Meat Technologies. [6]

Career

Yaakov Nahmias received his B.Sc. in Chemical Engineering and Biology from the Technion – Israel Institute of Technology, graduating Magna Cum Laude. [7] He completed his PhD at the University of Minnesota with David Odde, [8] and his postdoctoral training at Harvard Medical School with Martin Yarmush. In 2006, he became an independent investigator at Harvard Medical School, winning a NIH Research Scientist Development Award (K01). [9] Nahmias moved to the Hebrew University of Jerusalem in 2009, where he won two major European Research Council (ERC) Starting and Consolidator Grants, [10] [11] and founded the Alexander Grass Center for Bioengineering. In 2010, Nahmias became a Golda Meir fellow and a member of the ERC Starting Grant panel on applied life sciences and biotechnology (LS9). [12] In 2012, Nahmias together with Chaim Lotan, established BioDesign Israel, a multi-disciplinary program in medical innovation taught at the Hebrew University of Jerusalem and its affiliated Hadassah Medical Center. [13] [14]

Research

Nahmias is a liver biologist and a biomedical engineer who took part in the development of Lodamin, the first oral, broad-spectrum angiogenesis inhibitor [15] and the first decellularization of an intact liver for transplantation. [16] His own work showed that the Hepatitis C Virus (HCV) assembles on VLDL and that its production is blocked by the grapefruit flavonoid naringenin. [17] Nahmias' work is leading to a growing understanding of the role of diet and nutrition on liver metabolism, [18] including the first demonstration that gut bacteria affect liver development after birth, [19] and explaining the toxic effects of acetaminophen using liver-on-chip technology. [20]

Personal life

Nahmias is married to Michal Haimov, an attorney specializing in real estate and securities. The couple met at the University of Minnesota, are currently living in Eden Prairie and have three children.

Related Research Articles

<span class="mw-page-title-main">Technion – Israel Institute of Technology</span> Israeli research university in Haifa

The Technion – Israel Institute of Technology is a public research university located in Haifa, Israel. Established in 1912 by Jews under the dominion of the Ottoman Empire, the Technion is the oldest university in the country.

<span class="mw-page-title-main">Hebrew University of Jerusalem</span> Public research university in Israel

The Hebrew University of Jerusalem is a public research university based in Jerusalem, Israel. Co-founded by Albert Einstein and Chaim Weizmann in July 1918, the public university officially opened in April 1925. It is the second-oldest Israeli university, having been founded 30 years before the establishment of the State of Israel but six years after the older Technion university. The HUJI has three campuses in Jerusalem and one in Rehovot. Until 2023, the world's largest library for Jewish studies—the National Library of Israel—was located on its Edmond J. Safra campus in the Givat Ram neighbourhood of Jerusalem.

<span class="mw-page-title-main">Science and technology in Israel</span> National research, development and proficience of Israel

Science and technology in Israel is one of the country's most developed sectors. Israel spent 4.3% of its gross domestic product (GDP) on civil research and development in 2015, the highest ratio in the world. In 2019, Israel was ranked the world's fifth most innovative country by the Bloomberg Innovation Index. It ranks thirteenth in the world for scientific output as measured by the number of scientific publications per million citizens. In 2014, Israel's share of scientific articles published worldwide (0.9%) was nine times higher than its share of the global population (0.1%).

<span class="mw-page-title-main">Aaron Ciechanover</span> Israeli biologist and Nobel Laureate

Aaron Ciechanover is an Israeli biologist who won the Nobel Prize in Chemistry for characterizing the method that cells use to degrade and recycle proteins using ubiquitin.

<i>Annual Review of Biomedical Engineering</i> Academic journal

Annual Review of Biomedical Engineering is an academic journal published by Annual Reviews. In publication since 1999, this journal covers the significant developments in the broad field of biomedical engineering with an annual volume of review articles. It is edited by Martin L. Yarmush and Mehmet Toner. As of 2024, Journal Citation Reports gave the journal has an impact factor of 12.8 ranking it fourth out of 122 journals in the category "Biomedical Engineering". As of 2021, Annual Review of Biomedical Engineering is being published as open access, under the Subscribe to Open model.

<span class="mw-page-title-main">Mehmet Toner</span> Turkish biomedical engineer (born 1958)

Mehmet Toner is a Turkish biomedical engineer. He is currently the Helen Andrus Benedict Professor of Surgery at Massachusetts General Hospital (MGH) and Harvard Medical School, with a joint appointment as professor at the Harvard-MIT Division of Health Sciences and Technology (HST).

<span class="mw-page-title-main">Rambam Health Care Campus</span> Hospital in Haifa, Israel

Rambam Health Care Campus commonly called Rambam Hospital, is a teaching hospital in the Bat Galim neighborhood of Haifa, Israel. Rambam Health Care Campus is a part of Tertiary Referral Center for Northern Israel, It was founded in 1938, in Palestine, 10 years before the establishment of the State of Israel.

<span class="mw-page-title-main">Sangeeta Bhatia</span> American nanotechnologist

Sangeeta N. Bhatia is an American biological engineer and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS) at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Bhatia's research investigates applications of micro- and nano-technology for tissue repair and regeneration. She applies ideas from computer technology and engineering to the design of miniaturized biomedical tools for the study and treatment of diseases, in particular liver disease, hepatitis, malaria and cancer.

Korkut Uygun is a Turkish chemical engineer and a medical researcher.

Martin (Maish) L. Yarmush is an academic, American scientist, physician, and engineer known for his work in biotechnology and bioengineering. His faculty career began in 1984 at MIT in the Department of Chemical Engineering as a Principal Research Associate and Lucille P. Markey Scholar in Biomedical Science. In 1988 he joined Rutgers University, as Professor of Chemical and Biochemical Engineering and a member of the Center of Advanced Biotechnology and Medicine. In 1995, he returned to the Boston area to serve as the Helen Andrus Benedict Professor of Surgery and Bioengineering in the Harvard-MIT Division of Health Sciences and Technology, and to establish the Center for Engineering in Medicine at the Harvard Affiliated Teaching Hospitals. In 2007 he returned to Rutgers to hold the Paul and Mary Monroe Endowed Chair in Science and Engineering and serve as Distinguished Professor in the Department of Biomedical Engineering. He also holds a Lecturer in Surgery and Bioengineering position at Harvard Medical School, and is a member of the Senior Scientific Staff at the Shriners children's hospital in Boston.

<span class="mw-page-title-main">BioLineRx</span>

BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.

Abraham Katzir is a Professor of Physics at Tel Aviv University, holding the Carol and Mel Taub Chair in Applied Medical Physics. He is the son of Professor Aharon Katzir, also a scientist, who was killed in 1972 in Ben-Gurion Airport by Japanese terrorists. His uncle, Professor Ephraim Katzir, was the President of Israel.

<span class="mw-page-title-main">Rafael Beyar</span> Israeli cardiologist, entrepreneur, and professor

Rafael (Rafi) Beyar is an Israeli medical doctor, entrepreneur, and professor who is the eighth director of Rambam Health Care Campus since 1996. Beyar, an authority on interventional cardiology, also continues to practice in his specialty of clinical invasive cardiology. Beyar is the editor of several books related to cardiology and electrophysiology, including Frontiers in Interventional Cardiology, Proceedings from International Meetings, Analysis of Cardiac Development: from Embryo to Old Age; and co-founder of Corindus Vascular Robotics.

<span class="mw-page-title-main">Hermona Soreq</span> Israeli biologist

Hermona Soreq is an Israeli professor of Molecular Neuroscience at The Hebrew University of Jerusalem. Best known for her work on the signaling of acetylcholine and its relevance in stress responses and neurodegenerative diseases such as Parkinson's and Alzheimer's.

<span class="mw-page-title-main">Yaakov Amidror</span> Israeli general and National Security Advisor

Yaakov Amidror is a former major general and National Security Advisor of Israel, and was also the head of the Research Department of Israeli military intelligence. Today, he is the Anne and Greg Rosshandler Senior Fellow at the Jerusalem Institute for Strategic Studies, a conservative security think tank.

<span class="mw-page-title-main">Michael Silbermann</span> Israeli maxillofacial surgeon and health educator

Michael Silbermann is an Israeli maxillofacial surgeon and health educator. He is currently the executive director of the Middle East Cancer Consortium.

Institute for Medical Research, Israel-Canada (IMRIC) is a research institute affiliated with the Faculty of Medicine of the Hebrew University of Jerusalem.

Ervin Sejdic is North York General Hospital's Research Chair in Artificial Intelligence for Health Outcomes. He focuses on biomedical signal processing, gait analysis, swallowing difficulties, advanced information systems in medicine, rehabilitation engineering, assistive technologies and anticipatory medical devices. He was previously a researcher at the Swanson School of Engineering, University of Pittsburgh, where he directs a research laboratory focused on engineering developments in medicine. His research has focused on creating computational biomarkers indicative of age- and disease-related changes in functional outcomes such as swallowing, gait and handwriting. In particular, he aims to develop clinically relevant solutions by fostering innovation in mechatronic systems that can be translated to bedside care. Due to his contributions in signal processing and biomedical engineering, Sejdic has been named to editorial positions of IEEE Signal Processing Magazine, BioMedical Engineering Online and IEEE Transactions on Biomedical Engineering.

<span class="mw-page-title-main">Akhilesh K. Gaharwar</span> Indian biomedical engineering researcher (born 1982)

Akhilesh K. Gaharwar is an Indian academic and a professor in the Department of Biomedical Engineering at Texas A&M University.

<span class="mw-page-title-main">Believer Meats</span> Israeli food technology company

Believer Meats, from 2018 to 2022 known as Future Meat Technologies, or Future Meat for short, is a biotechnology firm which produces cultured meat from chicken cells and is working on cultured lamb kebabs and beef burgers. Based in Israel, its main office is located in Jerusalem, while its primary production facility is operating in Rehovot. Future Meat Technologies mainly seeks to supply hardware and cell lines to manufacturers of cultured meat rather than directly selling food products to consumers. In November 2022, Future Meat Technologies rebranded to Believer Meats.

References

  1. ↑ וינרב, גלי (August 2015), "Boston Scientific "Interesting in increasing activity in Israel"", Globes, Israel: Globes, Israel Business Arena, retrieved 15 Oct 2015
  2. ↑ Biotech breakthroughs net two scientists Rappaport prize, Israel: Times of Israel, February 2014, retrieved 15 Oct 2015
  3. ↑ 2014 Rappaport Prize for Excellence in Biomedical Research Awarded to Hebrew University's Dr. Yaakov Nahmias, Israel: The Hebrew University of Jerusalem, February 2014, retrieved 15 Oct 2015
  4. ↑ LinkedIN Profile, April 2015, retrieved 15 Oct 2015
  5. ↑ ERC Panel Members 2011 (PDF), Belgium: European Research Council, July 2011, retrieved 2 June 2013
  6. ↑ Ricky Ben-David (25 November 2021). "Lab to table: Israeli tech kitchens cook up future of animal-free food". The Times of Israel. Retrieved 6 December 2021.
  7. ↑ Yaakov Nahmias CV, Israel: Hebrew University, August 2012, retrieved 28 May 2013
  8. ↑ Odde Lab Website, United States: University of Minnesota, April 2013, retrieved 2 June 2013
  9. ↑ NIH Project 1K01DK080241, United States: National Institute of Health, June 2013, retrieved 2 June 2013
  10. ↑ ERC Project TMIHCV, Belgium: CORDIS Europa, April 2010, retrieved 2 June 2013
  11. ↑ ERC Project OCLD, Belgium: CORDIS Europa, October 2016, retrieved 13 October 2016
  12. ↑ ERC Panel Members 2011 (PDF), Belgium: European Research Council, July 2011, retrieved 2 June 2013
  13. ↑ Jerusalem BioDesign: Medical Innovation, Israel: The Hebrew University of Jerusalem, Nov 2012, retrieved 2 June 2013
  14. ↑ Spin offs from the BioDesign program raised over $1.2 million in investments, won national awards and were featured in MassChallenge
  15. ↑ New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy For A Wide Range Of Cancers, United States: Science Daily, June 2008, retrieved 2 June 2013
  16. ↑ Uygun, Basak E.; Soto-Gutierrez, Alejandro; Yagi, Hiroshi; Izamis, Maria-Louisa; Guzzardi, Maria A.; Shulman, Carley; Milwid, Jack; Kobayashi, Naoya; Tilles, Arno; Berthiaume, Francois; Hertl, Martin; Nahmias, Yaakov; Yarmush, Martin L.; Uygun, Korkut (Sep 2010), "Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix", Nature Medicine, 16 (7), United States: Faculty of 10,000 Medicine: 814–820, doi:10.1038/nm.2170, PMC   2930603 , PMID   20543851 , retrieved 2 June 2013
  17. ↑ Hampton, Tracy (April 2008), "Grapefruit Compound Battles Hepatitis C", JAMA, 299 (13), United States: Journal of the American Medical Association: 1532, doi:10.1001/jama.299.13.1532, PMID   18387924
  18. ↑ Avior, Yishai; Bomze, David; Ramon, Ory; Nahmias, Yaakov (April 2013), "Flavonoids as dietary regulators of nuclear receptor activity", Food & Function, 4 (6), Britain: Royal Society of Chemistry: 831–44, doi:10.1039/C3FO60063G, PMC   3781338 , PMID   23598551
  19. ↑ Israeli Scientist Has Baby, Realizes How to Grow Viable Liver Cells in the Lab, Israel: Haaretz, July 2015, retrieved 15 Oct 2015
  20. ↑ Researchers: Acetaminophen toxic at lower levels than thought, Jerusalem: UPI, August 2015, retrieved 15 Oct 2015
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.